Experienced in Peripheral Neuropathy

Marcus P. Schmidt

Obere Zahlbacher Str. 69, 
Mainz, RP, DE 
Experienced in Peripheral Neuropathy
Obere Zahlbacher Str. 69, 
Mainz, RP, DE 
OverviewLocationsClinical Research

Overview

Marcus Schmidt practices in Mainz, Germany. Mr. Schmidt is rated as an Experienced expert by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Breast Cancer, Ovarian Cancer, Endometrial Cancer, Mastectomy, and Vulvectomy.

His clinical research consists of co-authoring 355 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Peripheral Neuropathy.

Gender
Male

Locations

Obere Zahlbacher Str. 69, Mainz, RP 55131, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Subjects With Unresectable Locally-advanced or Metastatic HER2+ Breast Cancer (HER2CLIMB-02)
Enrollment Status: Active_not_recruiting
Publish Date: August 07, 2025
Intervention Type: Drug
Study Drugs: tucatinib, T-DM1
Study Phase: Phase 3
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
A Randomized Multicenter Pivotal Study of CDX-011 (CR011-vcMMAE)in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast Cancer (The METRIC Study)
Enrollment Status: Completed
Publish Date: March 08, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

355 Total Publications

Non-starch carbohydrates as lever to improve cereal-based foods: The case of FODMAP and beta-glucans.
Non-starch carbohydrates as lever to improve cereal-based foods: The case of FODMAP and beta-glucans.
Journal: Advances in food and nutrition research
Published: September 26, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schmidt's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile